In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems. 
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.